Michelle Petri, MD, MPH
Disclosures: Consulting Fee-GlaxoSmithKline-Principal_Investigator Other_Role-Contirbutor to Belimumab Pregnancy Registry|Consulting Fee-EMD Serono-Other_Role-Chair, Data Safety Monitoring Board|Consulting Fee-Astellas Pharmaceuticals-Other_Role-Consultant|Consulting Fee-Medscape LLC-Other_Role-Consult on preparation of CME presentations|Consulting Fee-Amgen-Other_Role-Consulting meeting|Consulting Fee-Novartis AG-Other_Role-Consultant|Consulting Fee-Johnson and Johnson-Other_Role-Consulting|Consulting Fee-INOVA Diagnostics-Other_Role-Consulting|Consulting Fee-Decision Resources Group-Other_Role-Consulting-Market research|Consulting Fee-Momenta Pharmaceuticals, Inc.-Other_Role-Consulting|Consulting Fee-Blackrock pharmaceuticals-Other_Role-Consulting|Contracted Research-Exagen-Principal_Investigator-Research collaboration on complement diagnostics|Consulting Fee-Qiagen-Other_Role-Expert panel on Quality of Life|Contracted Research-AstraZeneca-Principal_Investigator-CB|Consulting Fee-UCB Pharmaceuticals-Other_Role-Consultant on clinical trials|Consulting Fee-Glenmark Pharmaceuticals-Other_Role-Consultant on steering committee
No Bio Available.